Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Prodict is a leading bioinformatics company specializing in the development of advanced protein-family data integration platforms, most notably its flagship 3DM system. The 3DM platform automatically collects, integrates, and analyzes vast amounts of protein-related data, including sequences, structures, mutations, and literature, to provide actionable insights for drug discovery and protein engineering. By organizing data into superfamily-specific databases, Bio-Prodict enables researchers to identify critical residues, predict the effects of mutations, and optimize lead compounds with high precision. The company's technology is widely utilized by major pharmaceutical companies and academic institutions to accelerate the discovery of novel therapeutics across diverse target classes such as GPCRs, kinases, and nuclear receptors. Bio-Prodict's services also include custom database creation and consultancy for complex protein engineering projects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3DM.